InnaMed went through Y Combinator in the Winter 2017 batch, describing itself as At-home blood testing: measure + analyze + enhance. Y Combinator's company directory lists it as Inactive. The directory does not say why a company stopped, and this page does not guess.
- Batch
- Winter 2017
- What they did
- At-home blood testing: measure + analyze + enhance.
- Industry
- Healthcare
- Team size
- 7
- Based
- San Francisco, CA, USA; Philadelphia, PA, USA
- Status
- Inactive, as listed by Y Combinator
Its batch
Winter 2017 had 116 companies in YC's listing: 54 Active, 29 Acquired, 0 Public and 33 Inactive, so InnaMed is one of 33 companies from that batch listed as Inactive (28%). Across YC batches at least two years old, 23% of companies are listed Inactive.
Statuses are Y Combinator's own listing in its public company directory, read on the date shown. YC's directory can drop companies altogether, so the Inactive counts here are a floor, not a full count of companies that stopped. Acquired and Public are as YC lists them; neither says anything about the price or the outcome for founders.
The record: InnaMed in the Y Combinator directory. Measured 2026-09-26 from Y Combinator's company directory.
YC Winter 2017All shut-down YC companiesYC outcomes
Tools for this story
Each opens in a new tab, filled in for InnaMed. With no account yet, you sign up free and land on the result.